Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
NINGBO INNO PHARMCHEM CO.,LTD. provides an in-depth look at the pharmacology of Ornidazole, a crucial antiprotozoal and antibacterial agent. Ornidazole, identified by its CAS number 16773-42-5, is a synthetic nitroimidazole derivative that plays a significant role in treating infections caused by protozoa and anaerobic bacteria.
The pharmacological action of Ornidazole is rooted in its ability to selectively target and disrupt the cellular processes of susceptible microorganisms. The Ornidazole antiprotozoal mechanism involves the reduction of its nitro group under anaerobic conditions, catalyzed by specific microbial enzymes like nitroreductases. This process yields highly reactive intermediates, including free radicals, which are toxic to the pathogen. These intermediates interact with and damage the microbial DNA, leading to strand breaks and inhibiting vital processes such as DNA replication and transcription. This mechanism is central to its efficacy against organisms like Entamoeba histolytica, Giardia lamblia, and Trichomonas vaginalis.
Clinically, Ornidazole is employed in a range of applications, including the treatment of amoebiasis, giardiasis, trichomoniasis, and bacterial vaginosis. Its effectiveness in treating post-operative infections, particularly in gynecological and abdominal surgeries, further underscores its importance. For healthcare providers and manufacturers, understanding the specific Ornidazole CAS 16773-42-5 uses is key to selecting the appropriate treatment. The availability of high-quality Ornidazole API, which can be sourced from reliable suppliers like NINGBO INNO PHARMCHEM CO.,LTD., is essential for ensuring therapeutic success.
A comprehensive understanding of pharmacology also includes knowledge of Ornidazole drug interactions. It's known to interact with certain medications, such as anticoagulants (e.g., warfarin) and muscle relaxants, which can alter their efficacy or increase the risk of adverse effects. Physicians must carefully consider these interactions when prescribing Ornidazole. Additionally, the Ornidazole synthesis chemical process impacts the final product's purity, which is critical for its pharmacological profile and safety.
The development and production of APIs like Ornidazole require adherence to strict quality standards. NINGBO INNO PHARMCHEM CO.,LTD. is committed to supplying Ornidazole that meets these rigorous requirements, ensuring that pharmaceutical companies have access to a reliable and effective ingredient for their formulations. The ongoing research into Ornidazole's properties and potential new applications continues to highlight its value in the pharmaceutical industry.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
